Mobile Eye-Drug Startup InnoRx Sold to SurModics in $38.7 Million Deal
InnoRx Pharmaceuticals, a Mobile company built around an implant that delivers drugs inside the eye for more than a year, has been acquired by Minnesota-based SurModics in a cash-and-stock deal…